Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
LAML | rs2040040 | chr1:114331645 | A/T | 6.0E-5 | 111 | 13.1 | 20.3 | 5.1 | KM Plot |
LAML | rs2053999 | chr2:3207693 | C/T | 5.94E-5 | 111 | 0 | 14.7 | 15.2 | KM Plot |
LAML | rs2057223 | chr6:127637374 | T/C | 1.86E-5 | 111 | 0.98 | 16.27 | 15.17 | KM Plot |
LAML | rs2074860 | chr19:2244072 | A/G | 0.000164 | 111 | 16.23 | 12.65 | 0.5 | KM Plot |
LAML | rs2091224 | chr7:64454022 | A/G | 9.06E-5 | 111 | 1.03 | 14.67 | 19.8 | KM Plot |
LAML | rs2112844 | chr19:12548494 | C/T | 1.87E-5 | 111 | 6.13 | 22.37 | 13.1 | KM Plot |
LAML | rs2144742 | chr6:127595786 | C/A | 1.86E-5 | 111 | 0.98 | 16.27 | 15.17 | KM Plot |
LAML | rs2144743 | chr6:127633810 | A/T | 1.86E-5 | 111 | 0.98 | 16.27 | 15.17 | KM Plot |
LAML | rs2149649 | chr14:90774974 | A/G | 2.15E-6 | 111 | 1.03 | 21.27 | 12.7 | KM Plot |
LAML | rs2167963 | chr2:3219529 | G/A | 5.94E-5 | 111 | 0 | 14.7 | 15.2 | KM Plot |
LAML | rs2168044 | chr2:39206386 | G/A | 0.000136 | 111 | 0 | 4.52 | 16.27 | KM Plot |
LAML | rs2180341 | chr6:127600630 | C/T | 1.86E-5 | 111 | 0.98 | 16.27 | 15.17 | KM Plot |
LAML | rs2236402 | chr14:90734378 | C/G | 5.86E-6 | 111 | 12.7 | 21.27 | 1.03 | KM Plot |
LAML | rs2240480 | chr2:242408219 | G/A | 8.12E-5 | 109 | 1.53 | 14.63 | 17.23 | KM Plot |
LAML | rs2241399 | chr19:16236004 | T/G | 9.99E-5 | 107 | 16.2 | 8.13 | 0 | KM Plot |